Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving antigen-antibody binding – specific binding protein...
Reexamination Certificate
2010-07-19
2011-12-06
Cheu, Jacob (Department: 1641)
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving antigen-antibody binding, specific binding protein...
C435S007200, C436S518000
Reexamination Certificate
active
08071316
ABSTRACT:
Detection of toxic gluten oligopeptides refractory to digestion and antibodies and T cells responsive thereto can be used to diagnose Celiac Sprue.
REFERENCES:
patent: 4203967 (1980-05-01), Gallo-Torres
patent: 4656253 (1987-04-01), Lewicki
patent: 4912120 (1990-03-01), Castelhano et al.
patent: 4929630 (1990-05-01), Castelhano et al.
patent: 5208021 (1993-05-01), Johnson et al.
patent: 5372933 (1994-12-01), Zamarron et al.
patent: 5716794 (1998-02-01), Tjota
patent: 5789180 (1998-08-01), Bernardin
patent: 5817523 (1998-10-01), Picarelli
patent: 5834428 (1998-11-01), Drucker
patent: 6197356 (2001-03-01), Girsh
patent: 6294320 (2001-09-01), Hruska et al.
patent: 6319726 (2001-11-01), Schuppan et al.
patent: 6319756 (2001-11-01), Duesman et al.
patent: 6395889 (2002-05-01), Robison
patent: 6410550 (2002-06-01), Coe et al.
patent: 6667160 (2003-12-01), Fine
patent: 6833447 (2004-12-01), Goldman et al.
patent: 6903246 (2005-06-01), Gallie
patent: 6962989 (2005-11-01), Pompejus et al.
patent: 7144569 (2006-12-01), Anderson et al.
patent: 7202216 (2007-04-01), Sollid et al.
patent: 7265093 (2007-09-01), Khosla et al.
patent: 7303871 (2007-12-01), Hausch et al.
patent: 7320788 (2008-01-01), Shan et al.
patent: 7462688 (2008-12-01), Khosla et al.
patent: 7534426 (2009-05-01), Piper et al.
patent: 7579313 (2009-08-01), Khosla et al.
patent: 7605150 (2009-10-01), Khosla et al.
patent: 2001/0007690 (2001-07-01), Girsh
patent: 2001/0036639 (2001-11-01), Fine
patent: 2002/0039599 (2002-04-01), Lin et al.
patent: 2002/0076834 (2002-06-01), Detlef et al.
patent: 2003/0215438 (2003-11-01), Hausch et al.
patent: 2003/0224476 (2003-12-01), Chou
patent: 2004/0167069 (2004-08-01), Khosla et al.
patent: 2004/0241664 (2004-12-01), Dekker et al.
patent: 2005/0031603 (2005-02-01), Hubertus et al.
patent: 2005/0049064 (2005-03-01), Gagne
patent: 2005/0090653 (2005-04-01), Klaveness et al.
patent: 2005/0244823 (2005-11-01), Drijfhout et al.
patent: 2006/0052308 (2006-03-01), Khosla et al.
patent: 2006/0178299 (2006-08-01), Anderson et al.
patent: 2006/0240475 (2006-10-01), Khosla et al.
patent: 2008/0299108 (2008-12-01), Khosla et al.
patent: 2009/0156490 (2009-06-01), Khosla et al.
patent: 2009/0220554 (2009-09-01), Griffin et al.
patent: 2009/0304754 (2009-12-01), Robic
patent: 0237082 (1987-09-01), None
patent: 0905518 (1999-03-01), None
patent: 9426774 (1994-11-01), None
patent: 9610034 (1996-04-01), None
patent: 0042213 (2000-07-01), None
patent: 0125793 (2001-04-01), None
patent: 03068170 (2003-08-01), None
patent: 03096984 (2003-11-01), None
patent: 03104273 (2003-12-01), None
patent: 2004045392 (2004-06-01), None
patent: 2005049064 (2005-06-01), None
Sturgess et al., “Wheat peptide challenge in coeliac disease”, The Lancet (1994), 343:758-761.
Vader et al. “The Gluten Response in Children with Celiac Sprue Disease is Directed Toward Multiple Gliadin and Glutenin Peptides” Gastroenterology (2002), 122:1729-1737.
Vader et al. “The HLA-DQ2 Gene Dose Effect in Celiac Disease is Doirectly Related to the Magnitude and Breadth of Gluten-Specific T Cell Responses” PNAS, Oct. 14, 2003, 123(3):12390-12395.
Watts; et al., “Structure-activity relationship analysis of the selective inhibition of transglutaminase 2 by dihydroisoxazoles”, Journal of Medicinal Chemistry (2006), 49(25):7493-7501.
Wieser, “Relation Between Structure An Dcoeliac Toxicity” Acta Paediatr Suppl. (1996), 412:3-9.
Wieser “The Precipitating Factor in Coeliac Disease” Baillieres Clinical Gastroenterol (1995), 9(2):191-207.
Wruble, Milton, “Enteric Coating. I. A Laboratory Method for the Study and Control of Enteric Coatings”, Journal of the American Pharmaceutical Association, Jul. 1935, XXIV(7):570-574.
Xia; et al., Equilibrium and kinetic analysis of the unusual binding behavior of a highly immunogenic gluten peptide to HLA-DQ2, Biochemistry (2005), 44(11):4442-4449.
Yoshimoto et al., “Prolyl Endopeptidase FromFlavobacterium meningosepticum: Cloning and Sequencing of the Enzyme Gene” J. Biochem. (1991), 110:873-8.
Zhang et al. “Identification of differentially expressed proteins in human glioblastoma cell lines and tumors” Glia., Apr. 15, 2003, 42(2):194-208.
Ahnen et al., “Intestinal aminooligopeptidase. In vivo synthesis on intracellular membranes of rat jejunum” J. Biol. Chem., 1982, pp. 12129-12135, vol. 257.
Arentz-Hansen et al. “Celiac Lesion T Cells Recognizes Epitopes that Cluster in Regions of Gliadins Rich in Proline Residues” Gastroenterology (2002), 123(3):803-809.
Arentz-Hansen et al., “The Intestinal T Cell Response to a—Gliadin in Adult Celiac Disease Is Focused on a Single Deamidated Glutamine Targeted by Tissue Transglutaminase” J. Exp. Med. (2000), 191:603-12.
Arentz-Hansen, et al., “Production of a Panel of Recombinant Gliadins for the Characterisation of T Cell Reactivity in Coeliac Disease” Gut. (2000), 46(1):46-51.
Auger; et al., “Solid-State 13C NMR Study of a Transglutaminase-Inhibitor Adduct”, Biochemistry (1993), 32:3930-3934.
Bethune, et al. “Heterologous expression, purification, refolding, and structural-functionalcharacterization of EP-B2, a self-activating barley cysteine endoprotease,” (2006) Chemistry & Biology, 13:637-647.
Bordusa et al., “The Specificity Of Prolyl Endopeptidase FromFlavobacterium meningoseptum: Mapping the S′ Subsites By Positional Scanning Via Acyl Transfer” Bioorg. Med. Chem. (1998), 6:1775-80.
Campbell, “Monoclonal Antibody Technology”, Elsevier Science Publishers (1984), Section 1.3.4, pp. 1-32.
Castelhano et al., “Synthesis, Chemistry, and Absolute Configuratin of Novel Transglutaminiase Inhibitors Containing a 3-Halo-4,5-dihydroisoxazole” Bioorg. Chem. (1988), 16:335-340.
Choi et al. “Chemistry and Biology of Dihydroisoxazole Derivatives: Selectives Inhibitors of Human Transglutaminase 2” Chem. & Biol.(2005), 12:469-475.
Colot et al. “The Genes Encoding Wheat Storage Proteins: Towards A Molecular Understanding Of Bread-Making Quality And Its Genetic Manipulation” Genet Eng (1990), 12:225-41.
Cornell: et al., “In vitro mucosal digestion of synthetic gliadin-derived peptides in celiac disease”, Journal of Protein Chemistry (1995), 14(5):335-339.
Database Derwent, Acc-No. 1996-329479, JP-08151396A, “HLA-binding oligopeptide and an immuno: regulator contg, it-used in the treatment of auto: immune diseases” Abstract, Jun. 11, 1996.
de Ritis G. et al. “In Vitro (organ culture) Studies of the Toxicity of Specific A-Gliadin Peptides in celiac Disease” Gastroenbterology (1988), 94:41-9.
Frazer et al. “Gluten-induced enteropathy: the effect of partially digested gluten.” Lancet, Sep. 5, 1959, 2:252-255.
Freund, K., et al. “Transglutaminase Inhibition by 2-[(2-Oxopropyl)thio]imidazolium Derivatives: Mechanism of Factor XIIIa Inactivation,” Biochemistry (1994 ), 33:10109-10119.
Garcia-Maroto, et al., “Nucleotide Sequence of a cDNA Encoding an Alpha/Beta-Type Gliadin from Hexaploid Wheat (Triticum Aestivum)” Plant Molecular Biol. (1990), 14(5):867-868.
Goldsmith; et al., “Inhibition of Human Epidermal Transglutaminases In-Vitro and In-Vivo by Tyrosineamidomethyldihydrohaloisoxazoles”, Journal of Investigative Dermatology (1991), 97(1):156-158.
Greenberg, C. et al. “Transglutaminases: multifunctional cross-linking enzymes that stabilize tissues” FASEB J. (1991), 5:3071-3077.
Hartmann, G., et al., “Rapid degradation of gliadin peptides toxic for coeliac disease patients by proteases from germinating cereals,” (2006) 44368-371.
Hausch et al. “Design, synthesis, and evaluation of gluten peptide analogs as selective inhibitors of human tissue transglutaminase” Chem Biol., Mar. 2003, 10(3):225-31.
Hausch et al., “Intestinal digestive resistance of immun
Khosla Chaitan
Shan Lu
Bozicevic Field & Francis LLP
Cheu Jacob
Sherwood Pamela J.
The Board of Trustees of the Leland Stanford Junior University
LandOfFree
Diagnostic method for celiac sprue does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Diagnostic method for celiac sprue, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Diagnostic method for celiac sprue will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4315506